MSB 5.24% $1.11 mesoblast limited

Cell Therapy News/Articles, page-10730

  1. 5,588 Posts.
    lightbulb Created with Sketch. 2026
    We agree on nothing. You are speaking nonsense. You spoke of running a trial comparing something to prevent aGVHD with something meant to treat it. You speak of wide mortality ranges that don't even include patients with GVHD. You speak gibberish.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.